Co-Authors
This is a "connection" page, showing publications co-authored by Thomas FitzGerald and Paul Rava.
Connection Strength
0.466
-
Sioshansi S, Rava PS, Karam AR, Lithgow M, Ding L, Xing W, FitzGerald TJ. Diaphragm injury after liver stereotactic body radiation therapy. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):e227-30.
Score: 0.138
-
Garg R, Foley K, Movahedi B, Masciocchi MJ, Bledsoe JR, Ding L, Rava P, Fitzgerald TJ, Sioshansi S. Outcomes After Stereotactic Body Radiation Therapy as a Bridging Modality to Liver Transplantation for Hepatocellular Carcinoma. Adv Radiat Oncol. 2021 Jan-Feb; 6(1):100559.
Score: 0.054
-
Varlotto JM, Emmerick I, Voland R, DeCamp MM, Flickinger JC, Maddox DJ, Herbert C, Griffin M, Rava P, Fitzgerald TJ, Oliveira P, Baima J, Sood R, Walsh W, McIntosh LJ, Lou F, Maxfield M, Rassaei N, Uy K. The Incidence of Node-Positive Non-small-Cell Lung Cancer Undergoing Sublobar Resection and the Role of Radiation in Its Management. Front Oncol. 2020; 10:417.
Score: 0.053
-
Lee P, Ma Y, Zacharias I, Bozorgzadeh A, Wilson S, Foley K, Rava P, Masciocchi M, Ding L, Bledsoe J, Fitzgerald TJ, Sioshansi S. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients With Child-Pugh B or C Cirrhosis. Adv Radiat Oncol. 2020 Sep-Oct; 5(5):889-896.
Score: 0.053
-
Varlotto JM, McKie K, Voland RP, Flickinger JC, DeCamp MM, Maddox D, Rava PS, Fitzgerald TJ, Walsh W, Oliveira P, Rassaei N, Baima J, Uy K. The Role of Race and Economic Characteristics in the Presentation and Survival of Patients With Surgically Resected Non-Small Cell Lung Cancer. Front Oncol. 2018; 8:146.
Score: 0.046
-
Varlotto JM, Voland R, McKie K, Flickinger JC, DeCamp MM, Maddox D, Rava P, Fitzgerald TJ, Graeber G, Rassaei N, Oliveira P, Ali S, Belani C, Glanzman J, Wakelee HA, Patel M, Baima J, Zhang J, Walsh W. Population-based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic disease. Cancer Med. 2018 04; 7(4):1211-1220.
Score: 0.046
-
Varlotto J, Flickinger J, Pavelic MT, Specht CS, Sheehan JM, Timek DT, Glantz MJ, Sogge S, Dimaio C, Moser R, Yunus S, Fitzgerald TJ, Upadhyay U, Rava P, Tangel M, Yao A, Kanekar S. Distinguishing grade I meningioma from higher grade meningiomas without biopsy. Oncotarget. 2015 Nov 10; 6(35):38421-8.
Score: 0.039
-
Varlotto J, DiMaio C, Grassberger C, Tangel M, Mackley H, Pavelic M, Specht C, Sogge S, Nguyen D, Glantz M, Saw C, Upadhyay U, Moser R, Yunus S, Rava P, Fitzgerald T, Glanzman J, Sheehan J. Multi-modality management of craniopharyngioma: a review of various treatments and their outcomes. Neurooncol Pract. 2016 Sep; 3(3):173-187.
Score: 0.038